MDT logo

MDTMedtronic Plc

$80.70
$0.50
(0.62%)
Overnight
Updated: 08:21 PM EDT·Prev Close $80.20
Reported EarningsJun 3
Mkt Cap$102.97B
Vol7.69M
27

Bearish Sentiment

How do you feel about MDT?

News
all
press releases
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care PR Newswire GALWAY, Ireland...
PR Newswire
News Placeholder
More News
News Placeholder
Medtronic Bets on Ablation, Robotics, and Hypertension
MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.
Zacks
News Placeholder
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.
Zacks
News Placeholder
Is Medtronic Stock a Buy at 14x Forward Earnings?
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
Zacks
News Placeholder
Why Medtronic Stock May Have Just Become the Best Buy in the Entire Healthcare Sector
Why Medtronic Stock May Have Just Become the Best Buy in the Entire Healthcare Sector...
Yahoo! Finance: News
News Placeholder
Medtronic plc (MDT) Acquires SPR Therapeutics to Enhance Pain Intervention Prospects
Medtronic plc (MDT) Acquires SPR Therapeutics to Enhance Pain Intervention Prospects...
Yahoo! Finance: News
News Placeholder
Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?
Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance...
Yahoo! Finance: News
News Placeholder
Is Medtronic (MDT) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Medtronic (MDT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks
News Placeholder
3 High-Yielding Dividend Stocks That Just Raised Their Payouts
Key PointsLowe's, Medtronic, and UnitedHealth Group have been solid dividend growth stocks over the years...
Nasdaq News: Markets
News Placeholder
Wall Street May Be Mispricing Medtronic, Analyst Says
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.read more...
Benzinga
<
1
2
...
>

Advertisement|Remove ads.